BrickBio, Inc.

Private

Waltham, MassachusettsHealthcare & Life Scienceshttps://www.brickbio.com/

Last Round

VC Round

Mar 18, 2024

Est. Valuation

$20M

Total Funding Raised

$5M

Company Overview

BrickBio, Inc. is a biotechnology company that develops a bioconjugation platform for the site-specific modification of proteins to create novel biologics and therapeutics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

bioconjugationprotein engineeringantibody-drug conjugatesADCprecision biologicsexpanded genetic codesynthetic amino acidssite-specific conjugationbiotech platformdrug discoverybispecific conjugatesviral vectorspredictive screeningbiopharma R&Dprotein modificationbiotech drug designAI drug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BrickBio, Inc. Comparables

Compare BrickBio, Inc. with similar companies based on industry and business-model similarity.

BrickBio, Inc. comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Lonza Group	75%
Constructive Bio	73%
Johnson & Johnson	70%

View all Comparables

BrickBio, Inc. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
VC Round	Mar 18, 2024
Series A	Nov 22, 2019

View all Funding Rounds

Key People

Founding team and executive leadership

John Boyce

Co-Founder, President & CEO, Chairman of the Board

Founding Team

BrickBio, Inc. Investors

Notable investors and investment history

BrickBio, Inc. investors
Investor	Rounds
Samsung Venture Investment	VC Round
TigerGene	Series A
Samsung Life Science Fund	VC Round

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Mar 18, 2024
Samsung Life Science Fund, Samsung Venture Investment, Samsung Bioepis, Samsung BioLogics, and Samsung C&T Corporation participated.

View all signals

BrickBio, Inc. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

BrickBio, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BrickBio, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersWaltham, Massachusetts

Employee Range8

Year Founded2019

Last FundingMar 18, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.